Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi = Journal of Biomedical Engineering = Shengwu Yixue Gongchengxue Zazhi|February 1, 2003
[The experimental research of the killing effect of energy-controllable steep pulse on tumor tissue in vitro]Lan Xiong, Caixin Sun, Daqiang Li, et al.Thrombosis Journal|May 23, 2021
Prevalence and impact of fibrinolytic dysregulation in patients with acute coronary syndromesHuaibin Wan, Xin Fan, Zhihao Wu, et al.Platelets|September 7, 2020
Whole blood dynamic platelet aggregation counting and 1-year clinical outcomes in patients with coronary heart diseases treated with clopidogrelHuaibin Wan, Weichao Han, Zhihao Wu, et al.Journal of Translational Medicine|June 7, 2022
Integration of radiogenomic features for early prediction of pathological complete response in patients with triple-negative breast cancer and identification of potential therapeutic targetsYing Zhang, Chao You, Yuchen Pei, et al.European Journal of Medicinal Chemistry|February 11, 2014
Integrating docking scores, interaction profiles and molecular descriptors to improve the accuracy of molecular docking: toward the discovery of novel Akt1 inhibitorsWenhu Zhan, Daqiang Li, Jinxin Che, et al.Cancer Science|May 17, 2022
RNA binding protein POP7 regulates ILF3 mRNA stability and expression to promote breast cancer progressionYanni Huang, Yizi Zheng, Ling Yao, et al.European Journal of Medicinal Chemistry|November 5, 2018
Design, synthesis, and biological evaluation of novel phenol ether derivatives as non-covalent proteasome inhibitorsJianjun Yu, Lei Xu, Duidui Hong, et al.European Journal of Medicinal Chemistry|January 7, 2019
Exploration of novel macrocyclic dipeptide N-benzyl amides as proteasome inhibitorsJianjun Yu, Jieyu Liu, Daqiang Li, et al.Journal of Medicinal Chemistry|May 15, 2023
Discovery of (S)-N-(2-Amino-4-fluorophenyl)-4-(1-(3-(4-((dimethylamino)methyl)phenyl)-6-oxopyridazin-1(6H)-yl)ethyl)benzamide as Potent Class I Selective HDAC Inhibitor for Oral Anticancer Drug CandidateDaqiang Li, Zhuo Zhang, Yalei Li, et al.Journal of Medicinal Chemistry|January 6, 2023
Discovery of Highly Selective Inhibitors of the Human Constitutive Proteasome β5c Chymotryptic SubunitWenhu Zhan, Daqiang Li, Priya Saha, et al.Pageof 2